Heather Bresch is Mylan's Executive Vice President and Chief Operating Officer[8/2016 CEO], responsible for the Company's global commercial and technical operations, strategic planning, business development and international affairs. She also oversees the integration of Mylan's recent acquisition of Merck Generics.
Throughout her 16-year career with Mylan, Bresch has held various positions of increasing responsibility. Most recently, she served as Mylan's Head of North American Operations and Chief Integration Officer. As Head of North American Operations, Heather was responsible for Mylan Pharmaceuticals, Mylan Technologies and UDL Laboratories. In her role as Chief Integration Officer, she managed the successful integration of Matrix Laboratories, in which Mylan took a controlling stake in January of 2007, and has been leading the integration team working with Merck Generics, which Mylan acquired in October 2007. Prior to these positions, she served as Senior Vice President of Strategic Development in the Office of the CEO.
In addition to her responsibilities within Mylan, Bresch has served two consecutive terms as Chairman of the Generic Pharmaceutical Association and one term as its Vice Chairman. She has been actively involved in critical industry issues, including the passage of the 2003 Medicare Modernization Act, a Congressional revision to the Hatch-Waxman Act of 1984, which helped to ensure consumer access to affordable pharmaceuticals.more » « less